Exercise throughout chemotherapy reduces cognitive impairment, inflammation
the ONA take:
According to a study presented at the 2015 American Society of Clinical Oncology annual meeting this week, researchers from the University of Rochester have found that patients with cancer who exercise throughout chemotherapy had reduced chronic inflammation and cognitive impairment.
For the phase III study, researchers enrolled 619 patients with early-stage cancer. Participants were randomly assigned to receive standard care (no prescribed exercise during chemotherapy) or a specialized program labelled EXCAP. Patients in the EXCAP group walked daily and used resistance bands as instructed while also wearing a pedometer to track steps walked.
Results showed that patients in the standard care group experienced reduced mobility and increased brain fogginess and memory problems. Those patients also had higher levels of blood inflammation. Subgroup analyses showed patients who received chemotherapy in 2-week cycles experienced the most benefit from EXCAP.
"To think that a very simple, low-cost, self-directed exercise prescription can create an anti-inflammatory response similar to a drug and protect against cognitive decline in people with cancer is innovative and very exciting," said Karen M. Mustian, PhD, MPH, associate professor in the University of Rochester Departments of Surgery and Radiation Oncology.
Patients with cancer who exercise throughout chemotherapy had reduced chronic inflammation and cognitive impairment.
- More Than Half of Melanomas Are Self-Detected, Especially by Women
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- Hydroxyurea May Improve Kidney Function in PV-Associated Nephrotic Syndrome
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Study Identifies Factors Associated With Infection-related Complications in ALL
- Immune Checkpoint-Related Neurotoxicity May Be More Common During Combination Treatment
- New Recommendations for Secondary Prevention of Cervical Cancer
- Nonadherence to Posttreatment Imaging Follow-up Common Among Breast Cancer Survivors
- HIIT Improves Cardiorespiratory Fitness in Patients With Resectable NSCLC
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|